Flashback [Regulatives / Guidelines]

posted by jag009  – NJ, 2012-04-05 19:51 (4401 d 08:29 ago) – Posting: # 8388
Views: 9,324

Hi Helmut,

❝ ❝ Should the lab adjust the concentration profile to remove the residual levels caused by the pre-dose concentration???? ie. using the t1/2 and determine the amount of pre-dose concentration remaining throughout the timepoints and subtract it from the respective concentrations.


❝ See above. I cannot imaging that any regulatory agency would accept this (any more).


Question, can the pre-dose (0 hr) concentration be set to 0 if it is less than 5% of Cmax? FDA that is...

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
78 visitors (0 registered, 78 guests [including 5 identified bots]).
Forum time: 04:20 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5